Search for:
About Zealand
About Us
Disease Spotlights
History
Corporate Management
Corporate Governance
Corporate Social Responsibility
Board of Directors
Videos About Zealand
Transparency Reporting
R&D
Our Focus
Product Pipeline
Glepaglutide for SBS
Dasiglucagon for CHI
Survodutide (BI 456906) GLP-1/Glucagon Dual Agonist
Petrelintide-ZP8396 (Amylin Analog)
Dapiglutide (GLP-1/GLP-2 Dual Agonist)
Dasiglucagon for BHAP Systems
Partnering and In-licensing
What are Peptides?
Peptide Platform Video
Investor
Investor Relations
Corporate Presentation
Stock Information
Shareholder Portal
Financial Calendar
Financial Reports
Events
Annual General Meeting
SEC Filings
Analyst Coverage
Prospectus
Media
Zealand News
Media Inquiry
Downloads
Careers
Zealand as a Workplace
Meet Us
Positions
Personal Data in the Recruitment Process
Disclaimer: Beware of Recruitment Fraud
Contact
« All Events
This event has passed.
Zealand Pharma’s Obesity R&D Event
December 5, 2023 @ 8:30 am
-
11:30 am
EST
«
Q3/9M 2023 Financial Results
Zealand Pharma at Goldman Sachs Healthcare C-Suite Unscripted Conference
»
December 5 @ 8:30 am – 11:30 am EST
Webcast replay
Presentation slides
Add to calendar
Google Calendar
iCalendar
Outlook 365
Outlook Live
Details
Date:
December 5, 2023
Time:
8:30 am - 11:30 am
EST
